My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 90

    1.

    Using the natural evolution of a rotavirus-specific human monoclonal antibody to predict the complex topography of a viral antigenic site.

    McKinney BA, Kallewaard NL, Crowe JE Jr, Meiler J.

    Immunome Res. 2007 Sep 18;3:8.

    PMID:
    17877819
    [PubMed]
    Free PMC Article

    Related citations

    2.

    VP6 capsid protein of chicken rotavirus strain CH2: sequence, phylogeny and in silico antigenic analyses.

    Buragohain M, Cherian SS, Prabhakar G, Chitambar SD.

    Virus Res. 2008 Nov;137(2):173-8. Epub 2008 Aug 21.

    PMID:
    18680770
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view.

    Thouvenin E, Schoehn G, Rey F, Petitpas I, Mathieu M, Vaney MC, Cohen J, Kohli E, Pothier P, Hewat E.

    J Mol Biol. 2001 Mar 16;307(1):161-72.

    PMID:
    11243811
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Evaluation of GRAMM low-resolution docking methodology on the hemagglutinin-antibody complex.

    Vakser IA.

    Proteins. 1997;Suppl 1:226-30.

    PMID:
    9485517
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.

    Kleinjung J, Petit MC, Orlewski P, Mamalaki A, Tzartos SJ, Tsikaris V, Sakarellos-Daitsiotis M, Sakarellos C, Marraud M, Cung MT.

    Biopolymers. 2000 Feb;53(2):113-28.

    PMID:
    10679615
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Antigenic analysis of avian rotavirus VP6 using monoclonal antibodies.

    Minamoto N, Sugimoto O, Yokota M, Tomita M, Goto H, Sugiyama M, Kinjo T.

    Arch Virol. 1993;131(3-4):293-305.

    PMID:
    7688504
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.

    Feng N, Lawton JA, Gilbert J, Kuklin N, Vo P, Prasad BV, Greenberg HB.

    J Clin Invest. 2002 May;109(9):1203-13.

    PMID:
    11994409
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    8.

    Identification of rotavirus VP6 residues located at the interface with VP2 that are essential for capsid assembly and transcriptase activity.

    Charpilienne A, Lepault J, Rey F, Cohen J.

    J Virol. 2002 Aug;76(15):7822-31.

    PMID:
    12097594
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    9.

    Modelling antibody-antigen interactions: ferritin as a case study.

    Helmer-Citterich M, Rovida E, Luzzago A, Tramontano A.

    Mol Immunol. 1995 Sep;32(13):1001-10.

    PMID:
    7476997
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.

    Garaicoechea L, Olichon A, Marcoppido G, Wigdorovitz A, Mozgovoj M, Saif L, Surrey T, Parreño V.

    J Virol. 2008 Oct;82(19):9753-64. Epub 2008 Jul 16.

    PMID:
    18632867
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    11.

    Mapping the subgroup epitopes of rotavirus protein VP6.

    López S, Espinosa R, Greenberg HB, Arias CF.

    Virology. 1994 Oct;204(1):153-62.

    PMID:
    7522369
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.

    Tulip WR, Varghese JN, Laver WG, Webster RG, Colman PM.

    J Mol Biol. 1992 Sep 5;227(1):122-48.

    PMID:
    1381757
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Structural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoprotein.

    Iacob RE, Keck Z, Olson O, Foung SK, Tomer KB.

    Biochim Biophys Acta. 2008 Mar;1784(3):530-42. Epub 2008 Jan 11.

    PMID:
    18230369
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    14.

    Molecular characterization of a subgroup specificity associated with the rotavirus inner capsid protein VP2.

    McDonald SM, Patton JT.

    J Virol. 2008 Mar;82(6):2752-64. Epub 2008 Jan 23.

    PMID:
    18216104
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    15.

    Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.

    Julien JP, Bryson S, Nieva JL, Pai EF.

    J Mol Biol. 2008 Dec 12;384(2):377-92. Epub 2008 Sep 18.

    PMID:
    18824005
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.

    Muller YA, Chen Y, Christinger HW, Li B, Cunningham BC, Lowman HB, de Vos AM.

    Structure. 1998 Sep 15;6(9):1153-67.

    PMID:
    9753694
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).

    Li Y, Li H, Smith-Gill SJ, Mariuzza RA.

    Biochemistry. 2000 May 30;39(21):6296-309.

    PMID:
    10828942
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking.

    Simonelli L, Beltramello M, Yudina Z, Macagno A, Calzolai L, Varani L.

    J Mol Biol. 2010 Mar 12;396(5):1491-507. Epub 2010 Jan 4.

    PMID:
    20053355
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Epitope mapping: the first step in developing epitope-based vaccines.

    Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y.

    BioDrugs. 2007;21(3):145-56. Review.

    PMID:
    17516710
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Structure of IL-17A in complex with a potent, fully human neutralizing antibody.

    Gerhardt S, Abbott WM, Hargreaves D, Pauptit RA, Davies RA, Needham MR, Langham C, Barker W, Aziz A, Snow MJ, Dawson S, Welsh F, Wilkinson T, Vaugan T, Beste G, Bishop S, Popovic B, Rees G, Sleeman M, Tuske SJ, Coales SJ, Hamuro Y, Russell C.

    J Mol Biol. 2009 Dec 18;394(5):905-21. Epub 2009 Oct 14.

    PMID:
    19835883
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk